Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 221

1.

Mucinous Ovarian Carcinoma. Reply.

Morice P, Leary A, Gouy S.

N Engl J Med. 2019 Jul 4;381(1):e3. doi: 10.1056/NEJMc1905728. No abstract available.

PMID:
31269389
2.

Should We Cease to Perform Salvage Hysterectomy After Chemoradiation and Brachytherapy in Locally Advanced Cervical Cancer?

Gosset M, Chargari C, Bentivegna E, Leary A, Genestie C, Maulard A, Morice P, Gouy S.

Anticancer Res. 2019 Jun;39(6):2919-2926. doi: 10.21873/anticanres.13421.

PMID:
31177130
3.

Protective behavioral strategies and alcohol-related regretted sex among college students.

Peterson RS, Dvorak RD, Stevenson BL, Kramer MP, Pinto DA, Mora ET, Leary AV.

Exp Clin Psychopharmacol. 2019 Apr 22. doi: 10.1037/pha0000291. [Epub ahead of print]

PMID:
31008642
4.

Rucaparib in the landscape of PARP inhibition in ovarian cancer.

Colomba E, Pautier P, Pommeret F, Leary A.

Expert Rev Anticancer Ther. 2019 Jun;19(6):437-446. doi: 10.1080/14737140.2019.1607302. Epub 2019 May 16.

PMID:
30977683
5.

Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study.

Chung HC, Ros W, Delord JP, Perets R, Italiano A, Shapira-Frommer R, Manzuk L, Piha-Paul SA, Xu L, Zeigenfuss S, Pruitt SK, Leary A.

J Clin Oncol. 2019 Jun 10;37(17):1470-1478. doi: 10.1200/JCO.18.01265. Epub 2019 Apr 3.

PMID:
30943124
6.

Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study.

Colomban O, Tod M, Leary A, Ray-Coquard I, Lortholary A, Hardy-Bessard AC, Pfisterer J, Du Bois A, Kurzeder C, Burges A, Péron J, Freyer G, You B.

Clin Cancer Res. 2019 Apr 1. doi: 10.1158/1078-0432.CCR-18-3335. [Epub ahead of print]

PMID:
30936122
7.

Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1: Diagnostic exploration and staging, surgery, perioperative care, and pathology.

Lavoue V, Huchon C, Akladios C, Alfonsi P, Bakrin N, Ballester M, Bendifallah S, Bolze PA, Bonnet F, Bourgin C, Chabbert-Buffet N, Collinet P, Courbiere B, De la Motte Rouge T, Devouassoux-Shisheboran M, Falandry C, Ferron G, Fournier L, Gladieff L, Golfier F, Gouy S, Guyon F, Lambaudie E, Leary A, Lecuru F, Lefrere-Belda MA, Leblanc E, Lemoine A, Narducci F, Ouldamer L, Pautier P, Planchamp F, Pouget N, Ray-Coquard I, Rousset-Jablonski C, Senechal-Davin C, Touboul C, Thomassin-Naggara I, Uzan C, You B, Daraï E.

J Gynecol Obstet Hum Reprod. 2019 Jun;48(6):369-378. doi: 10.1016/j.jogoh.2019.03.017. Epub 2019 Mar 30.

8.

Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up).

Lavoue V, Huchon C, Akladios C, Alfonsi P, Bakrin N, Ballester M, Bendifallah S, Bolze PA, Bonnet F, Bourgin C, Chabbert-Buffet N, Collinet P, Courbiere B, De la Motte Rouge T, Devouassoux-Shisheboran M, Falandry C, Ferron G, Fournier L, Gladieff L, Golfier F, Gouy S, Guyon F, Lambaudie E, Leary A, Lecuru F, Lefrere-Belda MA, Leblanc E, Lemoine A, Narducci F, Ouldamer L, Pautier P, Planchamp F, Pouget N, Ray-Coquard I, Rousset-Jablonski C, Senechal-Davin C, Touboul C, Thomassin-Naggara I, Uzan C, You B, Daraï E.

J Gynecol Obstet Hum Reprod. 2019 Jun;48(6):379-386. doi: 10.1016/j.jogoh.2019.03.018. Epub 2019 Mar 29.

PMID:
30936025
9.

Determining acute nurse staffing: a hermeneutic review of an evolving science.

Leary A, Punshon G.

BMJ Open. 2019 Mar 30;9(3):e025654. doi: 10.1136/bmjopen-2018-025654.

10.

Mucinous Ovarian Carcinoma.

Morice P, Gouy S, Leary A.

N Engl J Med. 2019 Mar 28;380(13):1256-1266. doi: 10.1056/NEJMra1813254. Review. No abstract available.

PMID:
30917260
11.

Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa.

Lavoue V, Huchon C, Akladios C, Alfonsi P, Bakrin N, Ballester M, Bendifallah S, Bolze PA, Bonnet F, Bourgin C, Chabbert-Buffet N, Collinet P, Courbiere B, De la Motte Rouge T, Devouassoux-Shisheboran M, Falandry C, Ferron G, Fournier L, Gladieff L, Golfier F, Gouy S, Guyon F, Lambaudie E, Leary A, Lecuru F, Lefrere-Belda MA, Leblanc E, Lemoine A, Narducci F, Ouldamer L, Pautier P, Planchamp F, Pouget N, Ray-Coquard I, Rousset-Jablonski C, Senechal-Davin C, Touboul C, Thomassin-Naggara I, Uzan C, You B, Daraï E.

Eur J Obstet Gynecol Reprod Biol. 2019 May;236:214-223. doi: 10.1016/j.ejogrb.2019.03.010. Epub 2019 Mar 15.

PMID:
30905627
12.

Interphase Microtubules Safeguard Mitotic Progression by Suppressing an Aurora B-Dependent Arrest Induced by DNA Replication Stress.

Laflamme G, Sim S, Leary A, Pascariu M, Vogel J, D'Amours D.

Cell Rep. 2019 Mar 12;26(11):2875-2889.e3. doi: 10.1016/j.celrep.2019.02.051.

13.

[Management of epithelial ovarian cancer. Short text drafted from the French joint recommendations of FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa].

Lavoue V, Huchon C, Akladios C, Alfonsi P, Bakrin N, Ballester M, Bendifallah S, Bolze PA, Bonnet F, Bourgin C, Chabbert-Buffet N, Collinet P, Courbiere B, De la Motte Rouge T, Devouassoux-Shisheboran M, Falandry C, Ferron G, Fournier L, Gladieff L, Golfier F, Gouy S, Guyon F, Lambaudie E, Leary A, Lecuru F, Lefrere-Belda MA, Leblanc E, Lemoine A, Narducci F, Ouldamer L, Pautier P, Planchamp F, Pouget N, Ray-Coquard I, Rousset-Jablonski C, Senechal-Davin C, Touboul C, Thomassin-Naggara I, Uzan C, You B, Daraï E.

Bull Cancer. 2019 Apr;106(4):354-370. doi: 10.1016/j.bulcan.2019.01.014. Epub 2019 Mar 6. Review. French.

PMID:
30850152
14.

Nursing pay by gender distribution in the UK - does the Glass Escalator still exist?

Punshon G, Maclaine K, Trevatt P, Radford M, Shanley O, Leary A.

Int J Nurs Stud. 2019 May;93:21-29. doi: 10.1016/j.ijnurstu.2019.02.008. Epub 2019 Feb 13.

PMID:
30836236
15.

Characteristics and Prognosis of Stage I Ovarian Mucinous Tumors According to Expansile or Infiltrative Type.

Gouy S, Saidani M, Maulard A, Bach-Hamba S, Bentivegna E, Leary A, Pautier P, Devouassoux-Shisheboran M, Genestie C, Morice P.

Int J Gynecol Cancer. 2018 Mar;28(3):493-499. doi: 10.1097/IGC.0000000000001202.

PMID:
30814210
16.

Renal toxicities associated with pembrolizumab.

Izzedine H, Mathian A, Champiat S, Picard C, Mateus C, Routier E, Varga A, Malka D, Leary A, Michels J, Michot JM, Marabelle A, Lambotte O, Amoura Z, Soria JC, Kaaki S, Quellard N, Goujon JM, Brocheriou I.

Clin Kidney J. 2019 Feb;12(1):81-88. doi: 10.1093/ckj/sfy100. Epub 2018 Nov 9.

17.

CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary.

Xue Y, Meehan B, Macdonald E, Venneti S, Wang XQD, Witkowski L, Jelinic P, Kong T, Martinez D, Morin G, Firlit M, Abedini A, Johnson RM, Cencic R, Patibandla J, Chen H, Papadakis AI, Auguste A, de Rink I, Kerkhoven RM, Bertos N, Gotlieb WH, Clarke BA, Leary A, Witcher M, Guiot MC, Pelletier J, Dostie J, Park M, Judkins AR, Hass R, Levine DA, Rak J, Vanderhyden B, Foulkes WD, Huang S.

Nat Commun. 2019 Feb 4;10(1):558. doi: 10.1038/s41467-018-06958-9.

18.

[Part II drafted from the short text of the French guidelines entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Systemic and intraperitoneal treatment, elderly, fertility preservation, follow-up)].

Lavoué V, Huchon C, Akladios C, Alfonsi P, Bakrin N, Ballester M, Bendifallah S, Bolze PA, Bonnet F, Bourgin C, Chabbert-Buffet N, Collinet P, Courbiere B, De la Motte Rouge T, Devouassoux-Shisheboran M, Falandry C, Ferron G, Fournier L, Gladieff L, Golfier F, Gouy S, Guyon F, Lambaudie E, Leary A, Lécuru F, Lefrère-Belda MA, Leblanc E, Lemoine A, Narducci F, Ouldamer L, Pautier P, Planchamp F, Pouget N, Ray-Coquard I, Rousset-Jablonski C, Sénéchal-Davin C, Touboul C, Thomassin-Naggara I, Uzan C, You B, Daraï E.

Gynecol Obstet Fertil Senol. 2019 Feb;47(2):111-119. doi: 10.1016/j.gofs.2018.12.011. Epub 2019 Jan 28. French.

PMID:
30704955
19.
20.

[Part I drafted from the short text of the French Guidelines entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Diagnosis management, surgery, perioperative care, and pathological analysis)].

Lavoué V, Huchon C, Akladios C, Alfonsi P, Bakrin N, Ballester M, Bendifallah S, Bolze PA, Bonnet F, Bourgin C, Chabbert-Buffet N, Collinet P, Courbiere B, De la Motte Rouge T, Devouassoux-Shisheboran M, Falandry C, Ferron G, Fournier L, Gladieff L, Golfier F, Gouy S, Guyon F, Lambaudie E, Leary A, Lécuru F, Lefrère-Belda MA, Leblanc E, Lemoine A, Narducci F, Ouldamer L, Pautier P, Planchamp F, Pouget N, Ray-Coquard I, Rousset-Jablonski C, Sénéchal-Davin C, Touboul C, Thomassin-Naggara I, Uzan C, You B, Daraï E.

Gynecol Obstet Fertil Senol. 2019 Feb;47(2):100-110. doi: 10.1016/j.gofs.2018.12.010. Epub 2019 Jan 24. French.

PMID:
30686724
21.

Phase I dose-escalation study of F14512, a polyamine-vectorized topoisomerase II inhibitor, in patients with platinum-refractory or resistant ovarian cancer.

Leary A, Le Tourneau C, Varga A, Sablin MP, Gomez-Roca C, Guilbaud N, Petain A, Pavlyuk M, Delord JP.

Invest New Drugs. 2019 Aug;37(4):693-701. doi: 10.1007/s10637-018-0688-4. Epub 2018 Dec 14.

PMID:
30547316
22.

A randomized control trial of a deviance regulation theory intervention to increase alcohol protective strategies.

Dvorak RD, Troop-Gordon W, Stevenson BL, Kramer MP, Wilborn D, Leary AV.

J Consult Clin Psychol. 2018 Dec;86(12):1061-1075. doi: 10.1037/ccp0000347.

PMID:
30507231
23.

Modelling the Inflammatory Bowel Disease Specialist Nurse Workforce Standards by Determination of Optimum Caseloads in the UK.

Leary A, Mason I, Punshon G.

J Crohns Colitis. 2018 Nov 15;12(11):1295-1301. doi: 10.1093/ecco-jcc/jjy106.

PMID:
30445450
24.

Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas.

de Jonge MM, Auguste A, van Wijk LM, Schouten PC, Meijers M, Ter Haar NT, Smit VTHBM, Nout RA, Glaire MA, Church DN, Vrieling H, Job B, Boursin Y, de Kroon CD, Rouleau E, Leary A, Vreeswijk MPG, Bosse T.

Clin Cancer Res. 2019 Feb 1;25(3):1087-1097. doi: 10.1158/1078-0432.CCR-18-1443. Epub 2018 Nov 9.

PMID:
30413523
25.

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.

Moore K, Colombo N, Scambia G, Kim BG, Oaknin A, Friedlander M, Lisyanskaya A, Floquet A, Leary A, Sonke GS, Gourley C, Banerjee S, Oza A, González-Martín A, Aghajanian C, Bradley W, Mathews C, Liu J, Lowe ES, Bloomfield R, DiSilvestro P.

N Engl J Med. 2018 Dec 27;379(26):2495-2505. doi: 10.1056/NEJMoa1810858. Epub 2018 Oct 21.

PMID:
30345884
26.

Barriers to delivering advanced cancer nursing: A workload analysis of specialist nurse practice linked to the English National Lung Cancer Audit.

Stewart I, Leary A, Tod A, Borthwick D, Khakwani A, Hubbard R, Beckett P, Tata LJ.

Eur J Oncol Nurs. 2018 Oct;36:103-111. doi: 10.1016/j.ejon.2018.07.006. Epub 2018 Sep 6.

PMID:
30322500
27.

Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers.

Cottu PH, Bonneterre J, Varga A, Campone M, Leary A, Floquet A, Berton-Rigaud D, Sablin MP, Lesoin A, Rezai K, Lokiec FM, Lhomme C, Bosq J, Bexon AS, Gilles EM, Proniuk S, Dieras V, Jackson DM, Zukiwski A, Italiano A.

PLoS One. 2018 Oct 10;13(10):e0204973. doi: 10.1371/journal.pone.0204973. eCollection 2018.

28.

Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors.

Gouy S, Arfi A, Maulard A, Pautier P, Bentivegna E, Leary A, Chargari C, Genestie C, Morice P.

Oncologist. 2019 May;24(5):702-709. doi: 10.1634/theoncologist.2017-0632. Epub 2018 Sep 10.

PMID:
30201740
29.

Are working practices of lung cancer nurse specialists associated with variation in peoples' receipt of anticancer therapy?

Stewart I, Khakwani A, Hubbard RB, Beckett P, Borthwick D, Tod A, Leary A, Tata LJ.

Lung Cancer. 2018 Sep;123:160-165. doi: 10.1016/j.lungcan.2018.07.022. Epub 2018 Jul 17.

30.

Tension reduction and affect regulation: An examination of mood indices on drinking and non-drinking days among university student drinkers.

Dvorak RD, Stevenson BL, Kilwein TM, Sargent EM, Dunn ME, Leary AV, Kramer MP.

Exp Clin Psychopharmacol. 2018 Aug;26(4):377-390. doi: 10.1037/pha0000210. Epub 2018 Jul 9.

PMID:
29985019
31.

Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative.

Auguste A, Genestie C, De Bruyn M, Adam J, Le Formal A, Drusch F, Pautier P, Crosbie EJ, MacKay H, Kitchener HC, Powell M, Pollock PM, Mileshkin L, Edmondson RJ, Nout R, Nijman HW, Creutzberg CL, Bosse T, Leary A.

Mod Pathol. 2018 Dec;31(12):1851-1861. doi: 10.1038/s41379-018-0055-1. Epub 2018 Jun 28.

PMID:
29955143
32.

Host autophagy machinery is diverted to the pathogen interface to mediate focal defense responses against the Irish potato famine pathogen.

Dagdas YF, Pandey P, Tumtas Y, Sanguankiattichai N, Belhaj K, Duggan C, Leary AY, Segretin ME, Contreras MP, Savage Z, Khandare VS, Kamoun S, Bozkurt TO.

Elife. 2018 Jun 22;7. pii: e37476. doi: 10.7554/eLife.37476.

33.

Bevacizumab Does Not Reduce the Lymphocele Rate in Advanced Ovarian Cancer After Complete Cytoreductive Surgery.

Perrin M, Bentivegna E, Bonneau C, Uzan C, Leary A, Pautier P, Genestie C, Morice P, Gouy S.

Anticancer Res. 2018 Apr;38(4):2247-2252.

PMID:
29599346
34.

Multimodal Management of Locally Advanced Neuroendocrine Cervical Carcinoma: A Single Institution Experience.

Castelnau-Marchand P, Pautier P, Genestie C, Leary A, Bentivegna E, Gouy S, Scoazec JY, Morice P, Haie-Meder C, Chargari C.

Int J Gynecol Cancer. 2018 Jun;28(5):1013-1019. doi: 10.1097/IGC.0000000000001242.

PMID:
29595759
35.

International Study of Primary Mucinous Ovarian Carcinomas Managed at Tertiary Medical Centers.

Mueller JJ, Lajer H, Mosgaard BJ, Bach Hamba S, Morice P, Gouy S, Hussein Y, Soslow RA, Schlappe BA, Zhou QC, Iasonos A, Høgdall C, Leary A, O'Cearbhaill RE, Abu-Rustum NR.

Int J Gynecol Cancer. 2018 Jun;28(5):915-924. doi: 10.1097/IGC.0000000000001263.

36.

Characteristics and Prognosis of Stage I Ovarian Mucinous Tumors According to Expansile or Infiltrative Type.

Gouy S, Saidani M, Maulard A, Bach-Hamba S, Bentivegna E, Leary A, Pautier P, Devouassoux-Shisheboran M, Genestie C, Morice P.

Int J Gynecol Cancer. 2018 Mar;28(3):493-499. doi: 10.1097/IGC.0000000000001202.

PMID:
29466254
37.

Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study.

Banerjee S, Oza AM, Birrer MJ, Hamilton EP, Hasan J, Leary A, Moore KN, Mackowiak-Matejczyk B, Pikiel J, Ray-Coquard I, Trask P, Lin K, Schuth E, Vaze A, Choi Y, Marsters JC, Maslyar DJ, Lemahieu V, Wang Y, Humke EW, Liu JF.

Ann Oncol. 2018 Apr 1;29(4):917-923. doi: 10.1093/annonc/mdy023.

PMID:
29401246
38.

[Erratum to: "Histological and molecular classification of endometrial carcinoma and therapeutical implications" [Bull. Cancer 104 (2017) 1001-1012]].

Genestie C, Leary A, Devouassoux M, Auguste A.

Bull Cancer. 2018 Feb;105(2):214. doi: 10.1016/j.bulcan.2017.12.002. Epub 2018 Feb 1. French. No abstract available.

PMID:
29395040
39.

Author Correction: Interrogation of γ-tubulin alleles using high-resolution fitness measurements reveals a distinct cytoplasmic function in spindle alignment.

Shulist K, Yen E, Kaitna S, Leary A, Decterov A, Gupta D, Vogel J.

Sci Rep. 2018 Feb 1;8(1):2513. doi: 10.1038/s41598-018-19512-w.

40.

Modulation of plant autophagy during pathogen attack.

Leary AY, Sanguankiattichai N, Duggan C, Tumtas Y, Pandey P, Segretin ME, Salguero Linares J, Savage ZD, Yow RJ, Bozkurt TO.

J Exp Bot. 2018 Mar 14;69(6):1325-1333. doi: 10.1093/jxb/erx425.

41.

Crowd medical services in the English Football League: remodelling the team for the 21st century using a realist approach.

Leary A, Kemp A, Greenwood P, Hart N, Agnew J, Barrett J, Punshon G.

BMJ Open. 2017 Dec 21;7(12):e018619. doi: 10.1136/bmjopen-2017-018619.

42.

The humanized anti-human AMHRII mAb 3C23K exerts an anti-tumor activity against human ovarian cancer through tumor-associated macrophages.

Bougherara H, Némati F, Nicolas A, Massonnet G, Pugnière M, Ngô C, Le Frère-Belda MA, Leary A, Alexandre J, Meseure D, Barret JM, Navarro-Teulon I, Pèlegrin A, Roman-Roman S, Prost JF, Donnadieu E, Decaudin D.

Oncotarget. 2017 Oct 7;8(59):99950-99965. doi: 10.18632/oncotarget.21556. eCollection 2017 Nov 21.

43.

Results of Fertility-Sparing Surgery for Expansile and Infiltrative Mucinous Ovarian Cancers.

Gouy S, Saidani M, Maulard A, Bach-Hamba S, Bentivegna E, Leary A, Pautier P, Devouassoux-Shisheboran M, Genestie C, Morice P.

Oncologist. 2018 Mar;23(3):324-327. doi: 10.1634/theoncologist.2017-0310. Epub 2017 Dec 14.

44.

Impact of neoadjuvant chemotherapy on the immune microenvironment in advanced epithelial ovarian cancer: Prognostic and therapeutic implications.

Khairallah AS, Genestie C, Auguste A, Leary A.

Int J Cancer. 2018 Jul 1;143(1):8-15. doi: 10.1002/ijc.31200. Epub 2017 Dec 23. Review.

45.

Correction: Iron Pharmacokinetics in Women with Iron Deficiency Anaemia Following A Single Oral Dose of a Novel Formulation of Tardyferon (Prolonged Release Ferrous Sulphate).

Leary A, Barthe L, Clavel T, Sanchez C, Issiakhem Z, Paillard B, Edmond JM.

Drug Res (Stuttg). 2017 Nov;67(11):e1. doi: 10.1055/s-0043-123671. Epub 2017 Dec 5. No abstract available.

PMID:
29207435
46.

Spatial cues and not spindle pole maturation drive the asymmetry of astral microtubules between new and preexisting spindle poles.

Lengefeld J, Yen E, Chen X, Leary A, Vogel J, Barral Y.

Mol Biol Cell. 2018 Jan 1;29(1):10-28. doi: 10.1091/mbc.E16-10-0725. Epub 2017 Nov 15.

47.

[Abnormalities of DNA repair and gynecological cancers].

Auguste A, Leary A.

Bull Cancer. 2017 Nov;104(11):971-980. doi: 10.1016/j.bulcan.2017.09.007. Epub 2017 Oct 18. Review. French.

PMID:
29054544
48.

[Histological and molecular classification of endometrial carcinoma and therapeutical implications].

Genestie C, Leary A, Devouassoux M, Auguste A.

Bull Cancer. 2017 Dec;104(12):1001-1012. doi: 10.1016/j.bulcan.2017.08.004. Epub 2017 Oct 12. Review. French. Erratum in: Bull Cancer. 2018 Jan 30;:.

PMID:
29031505
49.

Is uterine preservation combined with bilateral salpingo-oophorectomy to promote subsequent fertility safe in infiltrative mucinous ovarian cancer?

Gouy S, Saidani M, Maulard A, Faron M, Bach-Hamba S, Bentivegna E, Leary A, Pautier P, Devouassoux-Shisheboran M, Genestie C, Morice P.

Gynecol Oncol Rep. 2017 Sep 28;22:52-54. doi: 10.1016/j.gore.2017.09.011. eCollection 2017 Nov.

50.

Ovarian Cancer: A Heterogeneous Disease.

Kossaï M, Leary A, Scoazec JY, Genestie C.

Pathobiology. 2018;85(1-2):41-49. doi: 10.1159/000479006. Epub 2017 Oct 12.

PMID:
29020678

Supplemental Content

Support Center